Stroke

Treatment Window for Using Clot Retrieval Device Now Expanded

By February 15, 2018

The Trevo device is inserted via a catheter into the blood vessel to the site of the clot. The end portion of the device expands (up to 3-6mm diameter) and grips the clot, allowing the physician to pull it back through the vessel along with the device.

FDA: New Clinical Decision Support Tool Helps ID Stroke Sooner

By February 14, 2018

The Viz.AI Contact application is a computer-aided triage software that uses an artificial intelligence algorithm to analyze images for indicators associated with a stroke.

Combo Tx Cuts Stroke Risk More Than BP, Cholesterol Drugs Alone

By January 25, 2018

The Heart Outcomes Prevention Evaluation Study was a large, international study involving over 12,000 patients from 21 countries.

No New Concerns With Rivaroxaban, According to FDA Mini-Sentinel Assessment

By January 16, 2018

The FDA analysis evaluated the safety of Xarelto in people with nonvalvular atrial fibrillation who initiated Xarelto or warfarin from November 2011 to April 2015.

Comparison of Oral Anticoagulants for Preventing Stroke in AF

By November 28, 2017

The greatest risk reduction of stroke or systemic embolism was seen with dabigatran 150mg twice daily (odds ratio [OR] 0.65, 95% CI: 0.52-0.81), followed by apixaban 5mg twice daily (OR 0.79, 95% CI: 0.66-0.94).

Victoza Approved to Reduce Risk of MACE

By August 28, 2017

The Food and Drug Administration (FDA) approval was based on data from the randomized, double-blind, placebo-controlled LEADER trial (n=9,340) that evaluated long-term effects of Victoza vs. placebo in patients with type 2 diabetes with high risk of major cardiovascular events (MACE).

Herpes Zoster Tied to Stroke Risk in Patients with Autoimmune Disease

February 03, 2017

For patients with autoimmune disease, herpes zoster tied to increased stroke risk in first 90 days